Community Health Workers: a Resource to Support Antipsychotic Medication Adherence

被引:4
作者
Allen, Caitlin G. [1 ]
Sugarman, Michael A. [2 ]
Wennerstrom, Ashley [3 ]
机构
[1] Boston Univ, Dept Med, 72 E Concord St, Boston, MA 02118 USA
[2] Wayne State Univ, Dept Psychol, 71 W Warren Ave, Detroit, MI 48202 USA
[3] Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA
关键词
SEVERE MENTAL-ILLNESS; PRIMARY-CARE; AFRICAN-AMERICANS; PATIENT-ADHERENCE; BIPOLAR DISORDER; SOCIAL SUPPORT; SCHIZOPHRENIA; DEPRESSION; PARTNERSHIPS; PREDICTORS;
D O I
10.1007/s11414-016-9515-x
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Community health workers (CHWs) are frontline public health workers who are becoming increasingly integrated into medical settings for the prevention, treatment, and control of chronic disease. In particular, they have demonstrated the ability to improve medication adherence in underserved populations. One overlooked population that could benefit from CHW intervention is individuals with severe mental illnesses such as schizophrenia and bipolar disorder. These conditions are disproportionally weighted to economically disadvantaged communities and people of color, and are typically treated using antipsychotic medications. A number of factors, including social disadvantage, contribute to antipsychotic non-adherence, which is highly prevalent and drastically increases the burden of illness and economic impact of these conditions. This commentary examines the ways in which CHWs may be able to best serve individuals with severe mental illness, and proposes methods for facilitating this expanded scope of work.
引用
收藏
页码:341 / 346
页数:6
相关论文
共 48 条
[31]  
O'Riordan M., 2014, WORLD C CARD SCI SES
[32]   Portrayals of Schizophrenia by Entertainment Media: A Content Analysis of Contemporary Movies [J].
Owen, Patricia R. .
PSYCHIATRIC SERVICES, 2012, 63 (07) :655-659
[33]   Effect of antidepressant drug counselling and information leaflets on adherence to drug treatment in primary care: randomised controlled trial [J].
Peveler, R ;
George, C ;
Kinmonth, AL ;
Campbell, M ;
Thompson, C .
BRITISH MEDICAL JOURNAL, 1999, 319 (7210) :612-615
[34]   Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder [J].
Robinson, DG ;
Woerner, MG ;
Alvir, JMJ ;
Bilder, RM ;
Hinrichsen, GA ;
Lieberman, JA .
SCHIZOPHRENIA RESEARCH, 2002, 57 (2-3) :209-219
[35]  
Rosenthal EL, FINAL REPORT NATL CO
[36]   Treatment adherence with antipsychotic medications in bipolar disorder [J].
Sajatovic, Martha ;
Valenstein, Marcia ;
Blow, Frederic C. ;
Ganoczy, Dara ;
Ignacio, Rosalinda V. .
BIPOLAR DISORDERS, 2006, 8 (03) :232-241
[37]   Racial disparities in psychotic disorder diagnosis: A review of empirical literature [J].
Schwartz, Robert C. ;
Blankenship, David M. .
WORLD JOURNAL OF PSYCHIATRY, 2014, 4 (04) :133-140
[38]   Risperidone Nonadherence and Return of Positive Symptoms in the Early Course of Schizophrenia [J].
Subotnik, Kenneth L. ;
Nuechterlein, Keith H. ;
Ventura, Joseph ;
Gitlin, Michael J. ;
Marder, Stephen ;
Mintz, Jim ;
Hellemann, Gerhard S. ;
Thornton, Leslie A. ;
Singh, Indira R. .
AMERICAN JOURNAL OF PSYCHIATRY, 2011, 168 (03) :286-292
[39]   Using drug claims data to assess the relationship of medication adherence with hospitalization and costs [J].
Svarstad, BL ;
Shireman, TI ;
Sweeney, JK .
PSYCHIATRIC SERVICES, 2001, 52 (06) :805-811
[40]  
Swartz MS, 1998, AM J PSYCHIAT, V155, P226